Piperacillin-Tazobactam, Cefepime Comparable for Suspected Infection

Incidence of acute kidney injury or death did not differ among those receiving cefepime and piperacillin-tazobactam

Related Keywords

United States ,Vanderbilt University ,Tennessee ,Boston ,Massachusetts ,American ,Edwardt Qian , ,Journal Of The American Medical Association ,Vanderbilt University Medical Center ,Infectious Diseases Society Of America Idweek ,Healthday News ,American Medical Association ,Infectious Diseases Society ,